These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11518063)
21. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells. Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078 [TBL] [Abstract][Full Text] [Related]
22. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver. Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810 [TBL] [Abstract][Full Text] [Related]
23. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [TBL] [Abstract][Full Text] [Related]
24. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)]. Güzelcan Y; Scholte WF; Assies J; Becker HE Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976 [TBL] [Abstract][Full Text] [Related]
25. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology]. Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742 [TBL] [Abstract][Full Text] [Related]
26. [Mechanism of action of St. Johns wort extract]. Müller WE; Singer A; Wonnemann M Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494 [TBL] [Abstract][Full Text] [Related]
27. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879 [TBL] [Abstract][Full Text] [Related]
28. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort. Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454 [TBL] [Abstract][Full Text] [Related]
29. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin. Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030 [TBL] [Abstract][Full Text] [Related]
30. Classification and correlation of St. John's wort extracts by nuclear magnetic resonance spectroscopy, multivariate data analysis and pharmacological activity. Roos G; Röseler C; Büter KB; Simmen U Planta Med; 2004 Aug; 70(8):771-7. PubMed ID: 15326551 [TBL] [Abstract][Full Text] [Related]
31. St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors. Langosch JM; Zhou XY; Heinen M; Kupferschmid S; Chatterjee SS; Nöldner M; Walden J Eur Neuropsychopharmacol; 2002 Jun; 12(3):209-16. PubMed ID: 12007672 [TBL] [Abstract][Full Text] [Related]
32. Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat. Franklin M; Chi JD; Mannel M; Cowen PJ J Psychopharmacol; 2000; 14(4):360-3. PubMed ID: 11198053 [TBL] [Abstract][Full Text] [Related]
33. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem). Murch SJ; Rupasinghe HP; Saxena PK Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339 [TBL] [Abstract][Full Text] [Related]
34. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats. Butterweck V; Winterhoff H; Herkenham M Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894 [TBL] [Abstract][Full Text] [Related]
35. St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects. Caccia S; Gobbi M Curr Drug Metab; 2009 Nov; 10(9):1055-65. PubMed ID: 20214594 [TBL] [Abstract][Full Text] [Related]
36. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848 [TBL] [Abstract][Full Text] [Related]
37. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Dimpfel W; Schober F; Mannel M Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945 [TBL] [Abstract][Full Text] [Related]
38. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex. Simbrey K; Winterhoff H; Butterweck V Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro. Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964 [TBL] [Abstract][Full Text] [Related]
40. Potential for interaction of kava and St. John's wort with drugs. Singh YN J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]